Should You Buy Bombardier (TSX:BBD.B) Stock?

Bombardier (TSX:BBD.B) trades for less than $0.50 per share today. Is the stock a contrarian buy?

| More on:
edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Bombardier (TSX:BBD.B) started 2020 near $2 per share.

The stock then suffered a severe meltdown due to the pandemic. A quick look at the share prices in recent years, however, indicates a troubling longer-term trend.

Trying to catch a falling knife is a dangerous game for investors. Cheap stocks often get a lot cheaper before they bounce. Some never recover and simply disappear or restructure under bankruptcy protection, effectively wiping out shareholder value. Others just get acquired at cents on the dollar. In a cash deal, shareholders simply book the loss and chalk it up as experience.

Once in a while, however, unloved stocks turn the corner and deliver huge gains for investors that had the courage to buy near the lows. Let’s take a look at Bombardier to see if it deserves to be on your contrarian buy list today.

Bombardier stock plunge

Bombardier traded for more than $25 per share in its glory days. Unfortunately, you have to follow the stock chart back 20 years to find the share price at that level. Aside from the odd head, Bombardier’s stock price has effectively been in a steady decline for two decades.

The bulk of the problems in recent years came as a result of the botched CSeries jet program. Bombardier’s new fuel-efficient jets should have been a major success. Unfortunately, the company encountered severe manufacturing delays that resulted in the program going billions of dollars over budget.

Early customers saw delivery schedules missed several times. Potential buyers simply stayed on the sidelines, waiting to see whether Bombardier could get the program back on track.

In the end, rising debt levels and massive cash burn forced management to shelve the dividend and seek financial assistance from Quebec and the province’s pension plan.

The company then sold the CSeries to Airbus. Airbus renamed the jets as A220.

Bombardier asset sales

Bombardier also sold off its other commercial aircraft divisions in the past couple of years. These included the Dash 8 turboprop operations and the CRJ regional jets.

On the train side, Bombardier announced a deal in February to sell its rail division to Alstom. Assuming the deal goes through as agreed, Bombardier would get as much as $4.5 billion in net proceeds.

This would leave Bombardier with just its business jet program. Management hoped strong sales of new models would right the ship. The pandemic now puts the future of the business jet market in question.

Bombardier debt risk

Bombardier has a market capitalization of roughly $1 billion. The company entered 2020 with more than US$9 billion in debt. Much of that is due in the next five years.

Business jet demand has to ramp up to ensure Bombardier generates enough cash flow to cover its obligations. That’s not guaranteed, especially in the current environment.

Proceeds from the assets sales will help reduce the debt load, but as the remaining debt comes due Bombardier will likely have to issue new debt to pay it off. Selling stock isn’t really an option at this point. Bond buyers might not be willing to take the chance on a new debt offering, even if Bombardier prices the bonds with a high interest rate.

Should you buy Bombardier stock?

Traders might be able pick up some quick profits on bits of good news. This was certainly the case in 2008, 2011, and 2018.

Investors with a buy-and-hold strategy, however, should probably seek out other opportunities in the market today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »